<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>45</viewCount><searchCount>0</searchCount></scores><additional><submitter>Diaz F</submitter><funding>American Heart Association</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Institutes of Health</funding><funding>Robert Wood Johnson Foundation</funding><pagination>618-624</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8532501</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>298(Pt A)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Healthcare workers (HCWs) treating patients with COVID-19 report psychological distress. We examined whether disturbed sleep was associated with psychological distress in New York City (NYC) HCWs during the initial peak of the COVID-19 pandemic (April-May 2020).&lt;h4>Methods&lt;/h4>HCWs completed a survey screening for acute stress (4-item Primary Care PTSD screen), depressive (Patient Health Questionaire-2), and anxiety (2-item Generalized Anxiety Disorder scale) symptoms. Insomnia symptoms (modified item from the Insomnia Severity Index) and short sleep (SS, sleep duration &lt;6 h/day) were assessed. Poisson regression analyses predicting psychological distress from SS and insomnia symptoms, adjusting for demographics, clinical role/setting, redeployment status, shifts worked, and multiple comparisons were performed.&lt;h4>Results&lt;/h4>Among 813 HCWs (80.6% female, 59.0% white) mean sleep duration was 5.8 ± 1.2 h/night. Prevalence of SS, insomnia, acute stress, depressive, and anxiety symptoms were 38.8%, 72.8%, 57.9%, 33.8%, and 48.2%, respectively. Insomnia symptoms was associated with acute stress (adjusted prevalence ratio [PR]: 1.51, 95% CI: 1.35, 1.69), depressive (PR: 2.04, 95% CI: 1.78, 2.33), and anxiety (PR: 1.74, 95% CI: 1.55, 1.94) symptoms. SS was also associated with acute stress (PR: 1.17, 95% CI: 1.07, 1.29), depressive (PR: 1.36, 95% CI: 1.233, 1.51), and anxiety (PR: 1.38, 95% CI: 1.26, 1.50) symptoms.&lt;h4>Limitations&lt;/h4>Our cross-sectional analysis may preclude the identification of temporal associations and limit causal claims.&lt;h4>Conclusions&lt;/h4>In our study, SS and insomnia were associated with psychological distress symptoms in NYC HCWs during the COVID-19 pandemic. Sleep may be a target for interventions to decrease psychological distress among HCWs.</pubmed_abstract><journal>Journal of affective disorders</journal><pubmed_title>The association between sleep and psychological distress among New York City healthcare workers during the COVID-19 pandemic.</pubmed_title><pmcid>PMC8532501</pmcid><funding_grant_id>R01HL141494</funding_grant_id><funding_grant_id>K23HL141682</funding_grant_id><funding_grant_id>R01HL146911</funding_grant_id><funding_grant_id>R01HL146636</funding_grant_id><pubmed_authors>Cornelius T</pubmed_authors><pubmed_authors>Schwartz JE</pubmed_authors><pubmed_authors>Cannone DE</pubmed_authors><pubmed_authors>Dong M</pubmed_authors><pubmed_authors>Venner H</pubmed_authors><pubmed_authors>McMurry CL</pubmed_authors><pubmed_authors>Shechter A</pubmed_authors><pubmed_authors>Sullivan AM</pubmed_authors><pubmed_authors>Lee SAJ</pubmed_authors><pubmed_authors>Diaz F</pubmed_authors><pubmed_authors>Abdalla M</pubmed_authors><pubmed_authors>Pham P</pubmed_authors><pubmed_authors>Bramley S</pubmed_authors><pubmed_authors>Shaw K</pubmed_authors><view_count>45</view_count></additional><is_claimable>false</is_claimable><name>The association between sleep and psychological distress among New York City healthcare workers during the COVID-19 pandemic.</name><description>&lt;h4>Background&lt;/h4>Healthcare workers (HCWs) treating patients with COVID-19 report psychological distress. We examined whether disturbed sleep was associated with psychological distress in New York City (NYC) HCWs during the initial peak of the COVID-19 pandemic (April-May 2020).&lt;h4>Methods&lt;/h4>HCWs completed a survey screening for acute stress (4-item Primary Care PTSD screen), depressive (Patient Health Questionaire-2), and anxiety (2-item Generalized Anxiety Disorder scale) symptoms. Insomnia symptoms (modified item from the Insomnia Severity Index) and short sleep (SS, sleep duration &lt;6 h/day) were assessed. Poisson regression analyses predicting psychological distress from SS and insomnia symptoms, adjusting for demographics, clinical role/setting, redeployment status, shifts worked, and multiple comparisons were performed.&lt;h4>Results&lt;/h4>Among 813 HCWs (80.6% female, 59.0% white) mean sleep duration was 5.8 ± 1.2 h/night. Prevalence of SS, insomnia, acute stress, depressive, and anxiety symptoms were 38.8%, 72.8%, 57.9%, 33.8%, and 48.2%, respectively. Insomnia symptoms was associated with acute stress (adjusted prevalence ratio [PR]: 1.51, 95% CI: 1.35, 1.69), depressive (PR: 2.04, 95% CI: 1.78, 2.33), and anxiety (PR: 1.74, 95% CI: 1.55, 1.94) symptoms. SS was also associated with acute stress (PR: 1.17, 95% CI: 1.07, 1.29), depressive (PR: 1.36, 95% CI: 1.233, 1.51), and anxiety (PR: 1.38, 95% CI: 1.26, 1.50) symptoms.&lt;h4>Limitations&lt;/h4>Our cross-sectional analysis may preclude the identification of temporal associations and limit causal claims.&lt;h4>Conclusions&lt;/h4>In our study, SS and insomnia were associated with psychological distress symptoms in NYC HCWs during the COVID-19 pandemic. Sleep may be a target for interventions to decrease psychological distress among HCWs.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2022-02-11T13:25:58.006Z</modification><creation>2022-02-11T13:25:58.006Z</creation></dates><accession>S-EPMC8532501</accession><cross_references><pubmed>34695497</pubmed><doi>10.1016/j.jad.2021.10.033</doi></cross_references></HashMap>